1120-77-0 Usage
Uses
Used in Pharmaceutical Research:
D-HOMOCYSTEINE THIOLACTONE HYDROCHLORIDE is used as a research compound for studying the role of moderate hyperhomocysteinemia in the development and progression of several diseases.
Used in Coronary Artery Disease Research:
D-HOMOCYSTEINE THIOLACTONE HYDROCHLORIDE is used as a research tool to investigate its potential association with coronary artery disease, aiming to understand the underlying mechanisms and develop targeted therapies.
Used in Alzheimer's Disease Research:
D-HOMOCYSTEINE THIOLACTONE HYDROCHLORIDE is used as a research agent to explore its connection to Alzheimer's disease, potentially contributing to the development of novel treatment strategies for this neurodegenerative condition.
Used in Schizophrenia Research:
D-HOMOCYSTEINE THIOLACTONE HYDROCHLORIDE is used as a research compound in the study of schizophrenia, helping researchers to uncover the relationship between hyperhomocysteinemia and the psychiatric disorder, which may lead to improved treatment options.
Check Digit Verification of cas no
The CAS Registry Mumber 1120-77-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1120-77:
(6*1)+(5*1)+(4*2)+(3*0)+(2*7)+(1*7)=40
40 % 10 = 0
So 1120-77-0 is a valid CAS Registry Number.
1120-77-0Relevant academic research and scientific papers
COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS
-
Page/Page column 45-49; 63, (2010/12/31)
The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.
Process for the resolution of homocysteine-thiolactone
-
Page/Page column 5, (2008/12/08)
The present invention relates to a process for the preparation of enantiomerically pure homocysteine-γ-thiolactone comprising optical resolution of racemic homocysteine-γ-thiolactone (I) with a chiral organic acid wherein one isomer is recovered as diastereomeric salt with the organic acid and the other isomer remaining in the mother liquor is submitted to racemisation with a catalytic amount of an aromatic aldehyde and submitted again to optical resolution with the same chiral organic acid.
